Dyslipidemia is strongly associated to MetS, nonalcoholic fatty liver disease (NAFLD) and is closely related with insulin resistance, since alteration of lipid metabolism and the increase of free fatty acid (FFA) flux inhibits insulin signaling leading to insulin resistance [8,9,53,56,63]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.